Multiparametric MRI for Prostate Cancer Localization and Characterization Using Hyperpolarized Pyruvate (13C) Injection

NCT02647983 · clinicaltrials.gov ↗

PHASE1

Phase

WITHDRAWN

Status

OTHER

Sponsor class

Stopped Lack of participants

Conditions

Prostatic Neoplasms

Interventions

DRUG: Hyperpolarized Pyruvate (13C) Injection

Sponsor

Sunnybrook Health Sciences Centre